Serenity: Blue Origin seeks funding at a $130 billion valuation, potentially benefiting the commercial aerospace sector
According to Odaily, "White-haired Stock God" Serenity posted on X stating that Blue Origin is seeking to raise $10 billion in funding, with a company valuation target of approximately $130 billion. If this round of financing is completed at this valuation, it will provide a new valuation benchmark for the commercial aerospace industry and may benefit other space-related companies such as RKLB and ASTS. If leading companies like SpaceX and Blue Origin are able to achieve such high market valuations, investors may re-evaluate the long-term value of companies throughout the entire space economy industry chain.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
A key leap toward the internationalization of the Korean won: The Bank of Korea launches a trial run of its 24/7 international settlement system, with full deployment set for January next year.
The Bank of Korea officially launched the trial operation of the "BOK Won International Payment Network" on Monday local time.
Offshore oil and gas module equipment company VME (VME.US) aiming for Nasdaq listing, plans to raise up to 30 million USD
Offshore oil and gas process module and separation equipment company VME Companies has applied for an IPO on Nasdaq, aiming to raise up to $30 million, with Kingswood as the sole bookrunner.
Hypertension drug developer Retension (RTSN.US) applies for US listing, plans to raise $58 million.
U.S. hypertension drug developer Retension Pharmaceuticals filed documents with the SEC last Friday, planning to raise up to $58 million through an initial public offering (IPO).
Pfizer (PFE.US) overseas price increase gains to be shared with the U.S. government: "Most Favored Nation" contract revealed, over twenty transactions still confidential
According to reports, under a new contract with the U.S. Department of Health and Human Services, Pfizer will share higher overseas drug revenues with the United States.
Crypto prices
More
